Does Betaseron cause weight gain?
Other side effects include: alopecia, dyspnea, hypertension, lower limb cramp, lymphadenopathy, palpitations, tachycardia, tissue necrosis at injection site, impotence, nervousness, peripheral vascular disease, urinary frequency, vasodilation, weight gain, malaise, and diaphoresis.
What kind of drug is Betaseron?
BETASERON® (interferon beta-1b) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
What is Betaseron used for?
This medication is used to treat multiple sclerosis (MS). Interferon is not a cure for MS, but it may help to slow disease worsening and decrease flare-ups of symptoms (such as balance problems, numbness, or weakness).
What company makes Betaseron?
Bayer acquired Betaferon/Betaseron (interferon beta 1b) through its recent purchase of Schering AG and its Bayer Schering Pharma unit has purchased Novartis’ biologics manufacturing facility in Emeryville, California, which is currently used to produce the drug for $110 million.
Can Betaseron cause liver damage?
Interferon beta is a well known cause of mild hepatic injury that occasionally can lead to severe liver injury with jaundice.
Is Betaseron an immunosuppressant drug?
Novantrone® (mitoxantrone), an anti-neoplastic drug, is the only approved immunosuppressive agent in MS. Betaseron and Rebif are the higher dosed IFNßs and are given subcutaneously every other day or three times per week, respectively.
Is Betaseron an immunosuppressant?
Is Betaseron generic?
Betaseron (interferon beta-1b) is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. There is currently no generic alternative to Betaseron.
Does Ocrevus increase liver enzymes?
Ocrelizumab is a humanized monoclonal antibody to CD20 which is used as therapy of multiple sclerosis. Ocrelizumab has not been associated with serum enzyme elevations during therapy nor with instances of idiosyncratic liver injury, but has been linked to cases of reactivation of hepatitis B in susceptible patients.
How often do you inject Betaseron?
The recommended starting dose is 0.0625 mg (0.25 mL) subcutaneously every other day, with dose increases over a sixweek period to the recommended dose of 0.25 mg (1 mL) every other day (see Table 1). If a dose of BETASERON is missed, then it should be taken as soon as the patient remembers or is able to take it.
How effective is Betaseron?
This is the longest follow-up study for any disease modifying therapy in multiple sclerosis (MS). Patients with relapsing forms of MS taking Betaseron (known as Betaferon® outside the US) had a sustained reduction in the annual rate of relapses of up to 40 percent over 16 years.
What happens when you become a Betaseron patient?
When you become a BETASERON patient, the program provides you with personalized one-on-one support throughout your treatment. That includes an MS-trained BETA Nurse available 24/7, training and helpful tools, practical resources, financial assistance, and more.
How long has Betaseron been in the market?
Right From the Start. BETASERON has over 25 years of clinical and patient experience since its launch in 1993 and provides a wide range of resources and services that we call BETAPLUS. When you become a BETASERON patient, the program provides you with personalized one-on-one support throughout your treatment.
What can a beta nurse do for MS?
An MS-trained BETA Nurse is available 24/7. A BETA Nurse gets to know you and, if you share your injection data, can follow your progress and provide proactive support. †
When to take interferon beta-1b for MS?
BETASERON® (interferon beta-1b) is a prescription medicine used to reduce the number of relapses in people with relapsing forms of multiple sclerosis (MS). This includes people who have had their first symptoms of multiple sclerosis and have an MRI consistent with multiple sclerosis.